Article

barrons.com on 2021-04-26 16:15

There's Room For More Players in the Covid-19 Vaccine Market, Analyst Says

CureVac is developing an mRNA-based Covid-19 vaccine now in clinical trials. An analyst at Guggenheim Securities believes shares could benefit.

Related news